121 related articles for article (PubMed ID: 22414726)
21. Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways.
Bilardi RA; Kimura KI; Phillips DR; Cutts SM
Biochem Pharmacol; 2012 May; 83(9):1241-50. PubMed ID: 22326903
[TBL] [Abstract][Full Text] [Related]
22. Interferon-β-armed oncolytic adenovirus induces both apoptosis and necroptosis in cancer cells.
Huang H; Xiao T; He L; Ji H; Liu XY
Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):737-45. PubMed ID: 22842821
[TBL] [Abstract][Full Text] [Related]
23. The role of the ATM/Chk/P53 pathway in mediating DNA damage in hand-foot syndrome induced by PLD.
Yang J; Qiao L; Zeng Z; Wang J; Zhu T; Wei J; Wu M; Ye S; Huang X; Ma D; Liu R; Gao Q
Toxicol Lett; 2017 Jan; 265():131-139. PubMed ID: 27923599
[TBL] [Abstract][Full Text] [Related]
24. Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent.
Cutts SM; Rephaeli A; Nudelman A; Ugarenko M; Phillips DR
Curr Top Med Chem; 2015; 15(14):1409-22. PubMed ID: 25866273
[TBL] [Abstract][Full Text] [Related]
25. A spatial physiological model for p53 intracellular dynamics.
Dimitrio L; Clairambault J; Natalini R
J Theor Biol; 2013 Jan; 316():9-24. PubMed ID: 22982291
[TBL] [Abstract][Full Text] [Related]
26. Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the ³²P-postlabeling technique.
Stiborova M; Poljakova J; Eckschlager T; Kizek R; Frei E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):115-21. PubMed ID: 22837132
[TBL] [Abstract][Full Text] [Related]
27. Non-apoptotic programmed cell death with paraptotic-like features in bleomycin-treated plant cells is suppressed by inhibition of ATM/ATR pathways or NtE2F overexpression.
Smetana O; Široký J; Houlné G; Opatrný Z; Chabouté ME
J Exp Bot; 2012 Apr; 63(7):2631-44. PubMed ID: 22268149
[TBL] [Abstract][Full Text] [Related]
28. Response of the G2-prophase checkpoint to genotoxic drugs in lymphocytes from healthy individuals.
Pincheira J; de la Torre C; Rodríguez N; Valenzuela CY
Biol Res; 2012; 45(2):177-82. PubMed ID: 23096362
[TBL] [Abstract][Full Text] [Related]
29. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response.
Kiran S; Oddi V; Ramakrishna G
Exp Cell Res; 2015 Feb; 331(1):123-141. PubMed ID: 25445786
[TBL] [Abstract][Full Text] [Related]
30. Formation of DNA adducts by formaldehyde-activated mitoxantrone.
Parker BS; Cullinane C; Phillips DR
Nucleic Acids Res; 1999 Jul; 27(14):2918-23. PubMed ID: 10390534
[TBL] [Abstract][Full Text] [Related]
31. Barminomycin functions as a potent pre-activated analogue of Adriamycin.
Moufarij MA; Cutts SM; Neumann GM; Kimura K; Phillips DR
Chem Biol Interact; 2001 Nov; 138(2):137-53. PubMed ID: 11672697
[TBL] [Abstract][Full Text] [Related]
32. Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damage.
Tomiyoshi G; Nakanishi A; Takenaka K; Yoshida K; Miki Y
Cancer Sci; 2008 Apr; 99(4):747-54. PubMed ID: 18307534
[TBL] [Abstract][Full Text] [Related]
33. CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.
Evison BJ; Bilardi RA; Chiu FC; Pezzoni G; Phillips DR; Cutts SM
Nucleic Acids Res; 2009 Oct; 37(19):6355-70. PubMed ID: 19720735
[TBL] [Abstract][Full Text] [Related]
34. Sequence specificity of adriamycin-DNA adducts in human tumor cells.
Cutts SM; Swift LP; Rephaeli A; Nudelman A; Phillips DR
Mol Cancer Ther; 2003 Jul; 2(7):661-70. PubMed ID: 12883039
[TBL] [Abstract][Full Text] [Related]
35. p53 elevation in relation to levels and cytotoxicity of mono- and bifunctional melphalan-DNA adducts.
Gould KA; Nixon C; Tilby MJ
Mol Pharmacol; 2004 Nov; 66(5):1301-9. PubMed ID: 15308759
[TBL] [Abstract][Full Text] [Related]
36. A switch in mechanism of action prevents doxorubicin-mediated cardiac damage.
Cheong A; McGrath S; Robinson T; Maliki R; Spurling A; Lock P; Rephaeli A; Nudelman A; Parker BS; Pepe S; Cutts SM
Biochem Pharmacol; 2021 Mar; 185():114410. PubMed ID: 33428897
[TBL] [Abstract][Full Text] [Related]
37. MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response.
Xuan F; Huang M; Zhao E; Cui H
Cell Death Dis; 2018 Oct; 9(11):1062. PubMed ID: 30333481
[TBL] [Abstract][Full Text] [Related]
38. DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1.
Boamah EK; Brekman A; Tomasz M; Myeku N; Figueiredo-Pereira M; Hunter S; Meyer J; Bhosle RC; Bargonetti J
Chem Res Toxicol; 2010 Jul; 23(7):1151-62. PubMed ID: 20536192
[TBL] [Abstract][Full Text] [Related]
39. Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin.
Lau DH; Durán GE; Sikic BI
J Natl Cancer Inst; 1992 Oct; 84(20):1587-92. PubMed ID: 1404452
[TBL] [Abstract][Full Text] [Related]
40. DNA biomarkers antecede semiquantitative anthracycline cardiomyopathy.
Hahm S; Dresner HS; Podwall D; Golden M; Winiarsky R; Moosikasuwan M; Cajigas A; Steinberg JJ
Cancer Invest; 2003; 21(1):53-67. PubMed ID: 12643010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
